"I see 2 scenarios for CS Medica, the stock has broken out of a declining trend and there is potential for upside in TP Zone 1 and also TP Zone 2. As mentioned, these are potential thoughts, with many fundamentals also supporting a push, such as the listing of the subsidiary in Germany at a valuation of 30 million euros, while CS is currently valued at 65 million DKK."
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.